Related Experiment Videos
Blood exchange with pyridoxalated and polymerized hemoglobin solution
Surgery, Gynecology & Obstetrics
|September 1, 1982
Summary
Modified hemoglobin solution ensured survival in rats after total blood exchange, unlike unmodified hemoglobin. This blood substitute demonstrated superior oxygen transport and reduced hemoglobin loss, proving beneficial for massive transfusions.
Area of Science:
- Biochemistry
- Physiology
- Biomedical Engineering
Background:
- Blood transfusions are critical for treating blood loss.
- Hemoglobin-based oxygen carriers (HBOCs) are being developed as alternatives.
- Pyridoxalated and polymerized hemoglobin offers potential advantages.
Purpose of the Study:
- To evaluate the in vivo efficacy of pyridoxalated and polymerized hemoglobin for total blood exchange.
- To compare survival rates and physiological parameters between modified and unmodified hemoglobin solutions.
Main Methods:
- Total blood exchange (93-95%) in rats using either modified or unmodified hemoglobin solution.
- Monitoring of survival, hematological, and physiological parameters.
- Assessment of oxygen-carrying capacity, P50 values, and plasma hemoglobin levels.
Main Results:
- All rats receiving modified hemoglobin survived, while control group rats died within 5 hours.
- Modified hemoglobin group showed higher oxygen capacity and P50 values post-transfusion.
- Plasma hemoglobin clearance was significantly slower with modified hemoglobin.
Conclusions:
- Pyridoxalated and polymerized hemoglobin is effective and beneficial for total blood exchange in vivo.
- This modified hemoglobin solution promotes survival after massive transfusions.
- It offers improved oxygen transport and sustained efficacy compared to unmodified hemoglobin.